Takeshi Okanoue

Summary

Affiliation: Saiseikai Kumamoto Hospital
Country: Japan

Publications

  1. pmc Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
    Yoshio Sumida
    Center for Digestive and Liver Diseases, Nara City Hospital, Nara, Japan
    BMC Gastroenterol 12:2. 2012
  2. doi request reprint Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
    Takeshi Okanoue
    Center of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan
    J Gastroenterol Hepatol 26:153-62. 2011
  3. doi request reprint Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
    Takeshi Okanoue
    Hepatology Center, Saiseikai Suita Hospital, 1 2 Kawazonocho, Suita, 564 0013, Japan
    J Gastroenterol 44:952-63. 2009
  4. doi request reprint Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
    Hyohun Park
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, 1 2 Kawazono cho, Suita, Osaka, 564 0013, Japan
    J Gastroenterol 46:101-7. 2011
  5. doi request reprint The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels
    Hyohun Park
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan
    Clin Chim Acta 411:1735-40. 2010
  6. doi request reprint Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy
    Takeshi Nishimura
    Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science Department of Internal Medicine, Aiseikai Yamashina Hospital, Kyoto Hepatology Center, Saiseikai Suita Hospital Department of Gastroenterology, Matsushita Memorial Hospital, Osaka, Japan
    Hepatol Res 42:966-73. 2012
  7. doi request reprint Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus
    Toshihide Shima
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Japan
    J Gastroenterol 48:515-25. 2013
  8. doi request reprint Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy
    Yoshito Itoh
    Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto Department of Gastroenterology, Matsushita Memorial Hospital Hepatology Center, Saiseikai Suita Hospital, Osaka Department of Gastroenterology and Hepatology Nara City Hospital, Nara, Japan
    Hepatol Res 41:1145-52. 2011
  9. pmc Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
    Masato Yoneda
    Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    BMC Gastroenterol 12:16. 2012
  10. doi request reprint Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
    Hyohun Park
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Kawazonocho 1 2, Suita, Osaka 564 0013, Japan
    J Gastroenterol 45:426-34. 2010

Collaborators

Detail Information

Publications11

  1. pmc Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
    Yoshio Sumida
    Center for Digestive and Liver Diseases, Nara City Hospital, Nara, Japan
    BMC Gastroenterol 12:2. 2012
    ..We validated the performance of FIB4 index in a Japanese cohort with NAFLD...
  2. doi request reprint Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
    Takeshi Okanoue
    Center of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan
    J Gastroenterol Hepatol 26:153-62. 2011
    ..Fortunately, we have been able to obtain very interesting results from our group studies, including single necleotide polymorphisms (SNPs) which will be published in the near future...
  3. doi request reprint Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
    Takeshi Okanoue
    Hepatology Center, Saiseikai Suita Hospital, 1 2 Kawazonocho, Suita, 564 0013, Japan
    J Gastroenterol 44:952-63. 2009
    ..Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients...
  4. doi request reprint Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
    Hyohun Park
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, 1 2 Kawazono cho, Suita, Osaka, 564 0013, Japan
    J Gastroenterol 46:101-7. 2011
    ..This study was designed to assess the efficacy of long-term EZ monotherapy in patients with NAFLD...
  5. doi request reprint The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels
    Hyohun Park
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan
    Clin Chim Acta 411:1735-40. 2010
    ..The study also assessed the effect of ezetimibe on CE levels...
  6. doi request reprint Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy
    Takeshi Nishimura
    Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science Department of Internal Medicine, Aiseikai Yamashina Hospital, Kyoto Hepatology Center, Saiseikai Suita Hospital Department of Gastroenterology, Matsushita Memorial Hospital, Osaka, Japan
    Hepatol Res 42:966-73. 2012
    ..The smaller SVR rate in female patients with cEVR compared to males may be overcome by extending treatment even if the RBV dose is lowered due to anemia...
  7. doi request reprint Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus
    Toshihide Shima
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Japan
    J Gastroenterol 48:515-25. 2013
    ..Our study aimed to clarify the clinicopathological features of liver injury and the characteristics of nonalcoholic fatty liver disease (NAFLD) in DM patients...
  8. doi request reprint Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy
    Yoshito Itoh
    Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto Department of Gastroenterology, Matsushita Memorial Hospital Hepatology Center, Saiseikai Suita Hospital, Osaka Department of Gastroenterology and Hepatology Nara City Hospital, Nara, Japan
    Hepatol Res 41:1145-52. 2011
    ....
  9. pmc Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
    Masato Yoneda
    Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    BMC Gastroenterol 12:16. 2012
    ..gingivalis), a major causative agent of periodontitis...
  10. doi request reprint Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
    Hyohun Park
    Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Kawazonocho 1 2, Suita, Osaka 564 0013, Japan
    J Gastroenterol 45:426-34. 2010
    ..Our aim was to determine whether hepatic SMP30 levels are associated with the development and progression of NAFLD...
  11. ncbi request reprint Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology
    Masatoshi Kudo
    Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka Sayama, Osaka, Japan
    Oncology 72:2-15. 2007
    ..In this article, the content of this manual, especially issues on surveillance, diagnosis, staging, and treatment, is summarized...